Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Rutgers Researcher Dr. Scott Kachlany Receives $4.4 Million Investment to Develop Cancer Therapy

7/19/2017

0 Comments

 
New Brunswick, NJ — Scott Kachlany, Ph.D., a Rutgers School of Dental Medicine researcher, has received a $4.4 million commitment in venture capital to bring a potential therapy for cancer and autoimmune diseases closer to human clinical trials, he announced yesterday.
 
Dr. Kachlany’s company, Actinobac Biomed Inc., is slated for funding from the California-based Kairos Ventures, which will pay for the final stages of preclinical development before his therapeutic technology, called Leukothera, is tested on humans.
 
Leukothera is based on Kachlany’s discovery that an oral bacterium, which causes periodontal disease, can produce a protein that can be used to kill leukemia cells in animals. 
​Leukothera is also a potential therapy for autoimmune and inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, Crohn’s disease, and HIV infection.
 
Toxicity tests on animals so far indicate that Leukothera is very well tolerated.  “Even at very high doses of the drug, there are no side effects,” said Dr. Kachlany, a Department of Oral Biology professor.
 
Dr. Kachlany plans to use the $4.4 million from Kairos to seek matching NIH funding that will enable Leukothera to be tested on humans with leukemia and lymphoma within the next three years.
 
Actinobac Biomed Inc. was started with an investment from Foundation Venture Capital Group (FVCG), Inc., an affiliate of New Jersey Health Foundation (NJHF).
 
“Rutgers is very excited about this important funding that will allow Actinobac to advance the Leukothera technology toward commercialization,” said S. David Kimball, PhD, associate vice president of Research Commercialization at Rutgers.
 
“This can have major implications for the treatment of blood cancer patients.  It also strengthens our relationship with NJHF and Kairos Ventures in our mutual effort to further support university innovation that benefits society.”
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619